ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,652, issued on Feb. 10, was assigned to SAREUM Ltd. (Cambridge, Great Britain).
"Crystalline forms of a TYK2 inhibitor" was invented by John Charles Reader (Cambridge, Great Britain), Jamie Conor Marshall (Northumberland, Great Britain), John Mykytiuk (Northumberland, Great Britain) and Julian Scott Northen (Tyne and Wear, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides crystalline forms of a compound having the formula (1):along with methods of making the crystalline forms and pharmaceutical formulations comprising the crystalline forms."
The patent was filed on April 6, 2021, under Application No. 17/905,183.
...